Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company LlcfiledCriticalWarner-Lambert Company Llc
Priority to CU20040160ApriorityCriticalpatent/CU23294A3/en
Publication of CU23294A3publicationCriticalpatent/CU23294A3/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Nitrogen Condensed Heterocyclic Rings
(AREA)
Abstract
La presente invención proporciona 2-aminopiridinas sustituidas útiles para tratar enfermedades proliferativas celulares. Los nuevos compuestos de la presente invención son potentes inhibidores de las quinasas 4 dependientes de ciclina (cdk4). ESPACIO PARA FÃ"RMULA</P>The present invention provides substituted 2-aminopyridines useful for treating cell proliferative diseases. The new compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4). SPACE FOR Fà "RMULA </P>